A Bayesian Group Sequential Approach for Multiple Endpoints

DOI10.1081/SQA-200046829MaRDI QIDQ4678861zbMATH OpenFDO

Authors Maria K. Mor, Stewart J. Anderson

Publication date 23 May 2005

Published in Sequential Analysis (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1081/SQA-200046829

zbMATH Keywords

Bayesian methodsclinical trialsgroup sequential designsmultiple endpoints

Mathematics Subject Classification ID

Bayesian problems; characterization of Bayes procedures (62C10) Bayesian inference (62F15) Multivariate analysis (62H99) Sequential statistical design (62L05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints
• Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints
• Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
• Bayesian statistics and the efficiency and ethics of clinical trials
• Nonparametric sequential testing in clinical trials with incomplete multivariate observations

Cites work

• Approaches for Optimal Sequential Decision Analysis in Clinical Trials
• Approximate Bayesian Evaluation of Multiple Treatment Effects
• Bayesian Approaches to Randomized Trials
• Bayesian Design and Analysis of Active Control Clinical Trials
• Bivariate Sequential Designs for Phase II Trials
• Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity
• Group Sequential Tests for Bivariate Response: Interim Analyses of Clinical Trials with Both Efficacy and Safety Endpoints
• scientific article; zbMATH DE number 3045589 (Why is no real title available?)
• Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials
• Monitoring Accumulating Data in a Clinical Trial
• On The Design and Analysis of Randomized Clinical Trials with Multiple Endpoints
• One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
• Testing Hypotheses About an Identified Treatment When There are Multiple Endpoints

Cited in

(2)

• Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers
• A Bayesian hierarchical monitoring design for phase cancer clinical trials: incorporating information on response duration into monitoring rules

This page was built for publication: A Bayesian Group Sequential Approach for Multiple Endpoints

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4678861)